LifeStance Health Group I... (LFST)

Live Updates Live Coverage Has Ended Goldman Bullish on Nuclear Stocks 12:05 pm by Gerelyn Terzo Goldman Sachs is bullish on two nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR)...

Live Updates Live Coverage Has Ended Wall Street Endorses Nuclear Stocks 12:10 pm by Gerelyn Terzo Goldman Sachs has issued a bullish report on a pair of nuclear stocks – Cameco (NYSE: CCJ) and NuScal...

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2025 Results Conference Call May 7, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ryan McGroarty - CFO David Bourdon - CEO Conference Ca...

LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.

The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon...

LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

I remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and ...

LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...